A signature for immune response correlates with HCV treatment outcome in Caucasian subjects

This data article contains Supplementary material for a published research article describing a whole-blood proteomic signature that predicts treatment outcome for subjects infected with hepatitis C virus (HCV) [1]. The proteomic signature is derived from whole-blood samples from subjects infected w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hare, Brian J., Haseltine, Eric, Fleming, Mark, Chelsky, Daniel, McIntosh, Laura, Allard, Rene, Botfield, Martyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510051/
https://www.ncbi.nlm.nih.gov/pubmed/26217718
http://dx.doi.org/10.1016/j.dib.2015.01.009
Descripción
Sumario:This data article contains Supplementary material for a published research article describing a whole-blood proteomic signature that predicts treatment outcome for subjects infected with hepatitis C virus (HCV) [1]. The proteomic signature is derived from whole-blood samples from subjects infected with HCV. The article includes detailed experimental and computational methods used in the analysis. The article also includes tables of demographic and other information about the subjects. Finally, the article includes several figures and tables showing detailed results of the analyses (e.g. lists of identified proteins and coefficients/ROC curves for the regression models).

Ejemplares similares